Cardiff Oncology Inc - Company Profile
Powered by
All the data and insights you need on Cardiff Oncology Inc in one report.
- Save hours of research time and resources with
our up-to-date Cardiff Oncology Inc Strategy Report
- Understand Cardiff Oncology Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Cardiff Oncology Catalyst Calendar
Proactively evaluate Cardiff Oncology Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Cardiff Oncology Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
08 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
31 Mar 2020 | Phase II Trial Results | Cardiff Oncology Inc; PRA Health Sciences Inc | CRDF | onvansertib fumarate | Oncology | Castration-Resistant Prostate Cancer (CRPC); Metastatic Castration-Resistant Prostate Cancer (mCRPC); Prostate Cancer | Company SEC Filings |
01 Dec 2019 | Phase I/II Trial Results | Cardiff Oncology Inc; PoC Capital LLC | CRDF | onvansertib fumarate | Oncology | Colorectal Cancer; Metastatic Colorectal Cancer | Company SEC Filings |
01 Dec 2019 | Phase I/II Trial Results | Cardiff Oncology Inc; PRA Health Sciences Inc | CRDF | onvansertib fumarate | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia | Company SEC Filings |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer